IntelliPharmaCeutics International (TSXV:IPCI) Price-to-Owner-Earnings : (As of May. 21, 2024)

IntelliPharmaCeutics International Price-to-Owner-Earnings Chart

IntelliPharmaCeutics International Annual Data
	Trend	Nov13	Nov14	Nov15	Nov16	Nov17	Nov18	Nov19	Nov20	Nov21	Nov22
Price-to-Owner-Earnings		Get a 7-Day Free Trial					-	-	-	-	-

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Price-to-Owner-Earnings	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of IntelliPharmaCeutics International's Price-to-Owner-Earnings

For the Biotechnology subindustry, IntelliPharmaCeutics International's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IntelliPharmaCeutics International's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Price-to-Owner-Earnings falls into.

IntelliPharmaCeutics International Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

IntelliPharmaCeutics International's Price-to-Owner-Earnings for today is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IntelliPharmaCeutics International  (TSXV:IPCI) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.

IntelliPharmaCeutics International Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (TSXV:IPCI) Business Description